Neal Bhatia, MD
Disclosures: Research Support-Allergan, Almirall/Aqua, Bayer, Biofrontera AG, Cipher, Ferndale, Galderma, IntraDerm, ISDIN, La Roche Posay, Mayne, Mylan, Novartis, Ortho Dermatologics Pierre Fabre, Promius Pharma, Sanofi/Regeneron, Skinfix, Sun Pharmaceutical, Valeant|Consultant/Advisor-Allergan, Almirall/Aqua, Bayer, Biofrontera AG, Cipher, Ferndale, Galderma, IntraDerm, ISDIN, La Roche Posay, Mayne, Mylan, Novartis, Ortho Dermatologics Pierre Fabre, Sanofi/Regeneron, Sun Pharmaceutical, Valeant|Compensation for Service on an Advisory Board-Promius Pharma, Skinfix|Research Support-Aclaris, Actavis, Asana, Atacama, BioPharmX, Brickell Biotech, Crown, Cutanea, Dermira, DUSA, Foamix, Glenmark, Leo Pharma, Menlo, Par, Perrigo, Pfizer, Realm, Sanofi/Regeneron, Sienna, Sol-Gel, Soligenix, Strata Skin, Viamet, Vidac, Vyome
NEAL D

 

 

NEal Bhatia, MD

DIRECTOR OF CLINICAL DERMATOLOGY

THERAPEUTICS CLINICAL RESEARCH

Associate Clinical professor

Harbor-ucla medical center

 

 

 

Dr. Neal Bhatia is a board-certified dermatologist in San Diego, California.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research. He has served as Program Director and Associate Clinical Professor at Harbor-UCLA Medical Center, as well as on AAD Board of Directors from 2011 until 2018.  He served as Scientific Chair for for several meetings and has presented in Spanish and Portuguese at international dermatology conferences.

 

Dr. Bhatia has been published in multiple journals and serves as chief medical editor for Practical Dermatology.  He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.  Aside from teaching at medical conferences, he sits on several editorial boards and is an active teacher for dermatologists, industry, and patients.